Further, F2RL3 methylation was suggested as a biomarker of smoking,40 and over‐expression and hypo‐methylation were associated with higher risk of lung cancer,41 and with tumor aggressiveness and poor survival in renal cancer.42 Here, F2RL3 is linked to neoplasm.